Catalyst Wire Dossier Catalyst Wire Dossier

Megestrol acetate (nanocrystalline formulation)

Megestrol acetate · Changchun GeneScience Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Megestrol acetate (nanocrystalline formulation), covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue [NA]

See pricing